Latest Research

A Prospective Observational Study of Demographic Profile and Clinicopathological Aspects in Young Patients with Colorectal Cancer.

Bavanasi RT, et al

Researchers at Nizams Institute of Medical Sciences in Telangana, India, conducted a prospective observational study examining the demographic and clinicopathological characteristics of 163 colorectal cancer (CRC) patients under the age of 50, a group defined as early-onset CRC. The study found that most patients (71.46%) were in the 41-50 age group with a mean age of 42.46 years, males comprised 64.4% of cases, and the rectum was the most frequent tumor site (44.9%). Critically, colon cancer patients most often presented at stage IV (38.8%), indicating widespread advanced disease at diagnosis, while lymphovascular and perineural invasion were detected in 55% and 35% of cases respectively, reflecting aggressive tumor biology. Signet ring cell carcinoma was disproportionately prevalent in patients under 30 years, mucinous tumors were more common in the 31-40 age group, and MSI-high status was identified in 18.57% of tumors, with patients carrying a family history presenting at earlier stages but with predominantly poorly differentiated histology. These findings underscore the urgent need for heightened clinical suspicion and earlier screening for CRC in younger Indian populations, as this demographic is presenting with advanced-stage disease and aggressive histological variants that demand prompt recognition and management.

Indian journal of surgical oncology

Mapping the Global Surge in Postoperative Sleep Research From 2014 to 2024: Bibliometric Analysis.

Wei X, et al

A new bibliometric study published in the Interactive Journal of Medical Research examined global research trends in postoperative sleep over the decade from 2014 to 2024, analyzing 964 publications retrieved from the Web of Science Core Collection. Researchers found that scientific output in this field has grown steadily, with China and the United States leading in publication volume, and institutions such as China Medical University and Capital Medical University at the forefront. The most frequently studied themes included sleep quality, postoperative pain, and quality of life, while emerging topics such as lung cancer, breast cancer, enhanced recovery after surgery, and the use of dexamethasone signal the field's evolving focus. Notably, anesthesiology emerged as the central discipline driving this research, with high-impact journals in that specialty attracting the most citations. These findings highlight that postoperative sleep disturbances are a growing concern in surgical care and that addressing them — particularly in cancer surgery patients — may be key to improving recovery outcomes. Clinicians and researchers are encouraged to consider sleep as a critical and measurable component of postoperative care protocols.

Interactive journal of medical research

Characterizing therapeutic target antigen expression in anaplastic carcinoma of the ovary.

Sullivan MW, et al

Researchers investigated whether four promising therapeutic targets — HER2, FOLR1, TROP2, and mismatch repair proteins — are expressed in anaplastic carcinoma of the ovary, a rare and aggressive cancer that frequently resists standard chemotherapy. The study retrospectively examined nine cases collected from institutional databases between 2013 and 2023, using immunohistochemical staining and tumor mutational burden analysis. Results showed that FOLR1, HER2, and TROP2 protein expression was either absent or present only at low levels, falling below the clinical thresholds required for eligibility to antibody-drug conjugate therapies such as mirvetuximab soravtansine. All nine tumors demonstrated intact mismatch repair function and low tumor mutational burden, with a median of just 3.3 mutations per megabase, making them unlikely to respond to immune checkpoint immunotherapy as well. These findings suggest that currently available targeted therapies and immunotherapies offer limited benefit for patients with anaplastic ovarian carcinoma, underscoring the urgent need to identify entirely new treatment strategies for this difficult-to-treat disease.

Gynecologic oncology reports

Anatomical Highlights During Nerve-Sparing Radical Hysterectomy: A Step-by-Step Educational Video.

Tanaka Y, et al

Researchers from Japan have published an educational surgical video detailing an eight-step technique for performing nerve-sparing radical hysterectomy in patients with cervical cancer larger than 2 centimeters, where this procedure remains the standard of care. The publication focuses on the critical importance of precise pelvic neurovascular anatomy, particularly the preservation of the hypogastric nerve and pelvic splanchnic nerves, which control bladder and bowel function after surgery. By systematically developing retroperitoneal avascular spaces using clearly defined anatomical landmarks, surgeons can minimize the risk of nerve injury, reduce intraoperative bleeding, and avoid unintentionally less radical resections. The eight steps guide the surgeon through dissection of pararectal and paravesical spaces, isolation of the ureter, separation of key neural structures, and careful management of the deep uterine vein relative to the inferior hypogastric plexus. This step-by-step approach, performed as a total laparoscopic procedure covered under Japan's public health insurance system, aims to make the technique reproducible and teachable for gynecologic oncology surgeons worldwide. Wider adoption of this standardized technique could improve postoperative quality of life for cervical cancer patients by reducing urinary and bowel complications associated with pelvic nerve damage.

Annals of surgical oncology

Mandato E, Yan Q, Ouyang J, et al. MYD88L265P augments proximal B-cell receptor signaling in large B-cell lymphomas via an Interaction with DOCK8. Blood. 2023;142(14):1219-1232.

This study investigated how the MYD88 L265P mutation — one of the most frequent oncogenic alterations in aggressive large B-cell lymphomas — enhances malignant cell survival and proliferation. Researchers discovered that the mutant MYD88 protein physically interacts with DOCK8, a guanine nucleotide exchange factor, to amplify proximal B-cell receptor (BCR) signaling, a key pathway that lymphoma cells exploit to grow and evade cell death. This interaction functionally bridges two major oncogenic networks — the innate immune TLR/MYD88 pathway and the BCR signaling cascade — providing a molecular explanation for the co-dependency on both pathways observed in activated B-cell diffuse large B-cell lymphoma (ABC-DLBCL). The discovery identifies the MYD88–DOCK8 protein complex as a potential therapeutic target, suggesting that disrupting this interaction could impair lymphoma cell survival. These findings are clinically meaningful because MYD88-mutant large B-cell lymphomas, including ABC-DLBCL and primary central nervous system lymphoma, carry a poor prognosis upon relapse and urgently need new treatment strategies.

Blood